Status not kept up to date
Impact of Tamsulosin on Voiding Patterns Following Early Catheter Removal After Robot-assisted Laparoscopic Radical Prostatectomy
NCT01209988 · Asan Medical Center · Updated 28 Sept 2010
- What is being tested
- tamsulosin 0.4mg; No medication
- For
- Prostatic Neoplasms, Prostatectomy
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages Not stated. About 220 people. The full rules are on the registry page.
- Where
- South Korea
- When
- Starts or started April 2010, ends Dec 2011. Registered 28 Sept 2010.
- Results
- None posted yet.
In the researchers' words
To date, there is a lack of consensus concerning the optimal timing for removal of the urethral catheter, its related complications, the effectiveness in prophylactic drug use to reduce complication, and the patient reported outcomes (quality of life) after robot-assisted laparoscopic prostatectomy (RALP). The purpose of this study is to determine the impact of tamsulosin on voiding patterns following early urethral catheter removal after RALP for prostate cancer.
Sites
- Asan Medical CenterSeoul, South Korea
